Status:
COMPLETED
Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Heterozygous Haemoglobinopathy
Eligibility:
FEMALE
18+ years
Brief Summary
This retrospective study aims to investigate pregnancy outcome in women with heterozygous hemoglobinopathies (regarding gestational diabetes, cholestasis and urinary tract infections) and to analyze i...
Eligibility Criteria
Inclusion
- pregnant women with or without heterozygous hemoglobinopathy
Exclusion
- refusal of study participation
Key Trial Info
Start Date :
April 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 11 2021
Estimated Enrollment :
540 Patients enrolled
Trial Details
Trial ID
NCT03837119
Start Date
April 4 2018
End Date
April 11 2021
Last Update
December 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Frauenklinik University Hospital Basel
Basel, Switzerland, 4031
2
Frauenklinik University Hospital Zürich
Zurich, Switzerland, 8091